Table 1. Primary clinical and laboratory characteristics of the study subjects.
Controls (N = 3) | DNI (N = 3) | DNII (N = 3) | |
Age (years) | 52.00±13.11 | 75.0±8.89# | 66.38±8.08# |
Sex (male/female) | 2/1 | 3/0 | 3/0 |
Diabetes duration(years) | − | 7.33±1.53 | 9.97±3.06 |
MBP (mmHg) | − | 109±4.6 | 112±6.2 |
HbA1c (%) | − | 7.16±0.69 | 7.18±0.57 |
Scr (µmol/l) | 83.00±13.23 | 75.57±8.57 | 122.97±6.21* |
Ualb (mg/g (Cr)) | 9.67±7.23 | 100.00±59.92 | 427.67±35.23* |
BUN (mmol/l) | 4.03±0.96 | 5.26±1.16 | 8.28±0.27* |
eGFR (ml/min/1.73 m2) | 87.84±9.03 | 99.22±12.72 | 55.16±3.60* |
#DNII group and DNI group vs. controls, p<0.05.
DNII group vs. DNI group and controls, p<0.05.